Primer Management, LLC

About

--> About Us | Primer Ventures top of page O ur portfolio company, Curio Bioscience, is acquired by Takara! News: Innovate Disrupt Transform About Us At Primer Ventures, we believe in the power of innovation and are committed to partnering with visionary entrepreneurs to transform healthcare. We focus on investing in breakthrough innovations and vast market opportunities in the fields of life science tools and therapeutics at early stage. W e empower entrepreneurs to accelerate the development and delivery of disruptive products and therapies to market. Our Focus Tools and Genomics Synthetic biology Genomics and proteomics Single cell spatial biology Next-gen analytical equipment Molecular diagnostics Manufacturing technologies Therapeutics New therapeutics modalities Genetics medicine New delivery methods Cell and gene therapies Regenerative medicines Omics and AI-enabled drug discovery Our Portfolio Companies Single-cell spatial profiling technology ​ (Acquired by Takara) Next-generation digital counting platform Targeted therapies tackling drug resistance Genetic medicine for autoimmune diseases bottom of page

Key Contact